BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 11232708)

  • 1. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
    Adams PC
    Am J Gastroenterol; 2001 Feb; 96(2):567-9. PubMed ID: 11232708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for hemochromatosis in asymptomatic subjects with or without a family history.
    Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML
    Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
    Kowdley KV; Brandhagen DJ; Gish RG; Bass NM; Weinstein J; Schilsky ML; Fontana RJ; McCashland T; Cotler SJ; Bacon BR; Keeffe EB; Gordon F; Polissar N;
    Gastroenterology; 2005 Aug; 129(2):494-503. PubMed ID: 16083706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels.
    Beaton M; Adams PC
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):713-4. PubMed ID: 18550006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of hereditary hemochromatosis patients who lack the C282Y mutation.
    Shaheen NJ; Bacon BR; Grimm IS
    Hepatology; 1998 Aug; 28(2):526-9. PubMed ID: 9696020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C282Y and H63D mutations of the haemochromatosis gene in patients with iron overload.
    Jorquera F; Domínguez A; Díaz-Golpe V; Espinel J; Muñoz F; Herrera A; Fernández-Gundín MJ; Vivas S; Olcoz JL
    Rev Esp Enferm Dig; 2001 May; 93(5):293-302. PubMed ID: 11488107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DMT1 genetic variability is not responsible for phenotype variability in hereditary hemochromatosis.
    Kelleher T; Ryan E; Barrett S; O'Keane C; Crowe J
    Blood Cells Mol Dis; 2004; 33(1):35-9. PubMed ID: 15223008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Iron storage disease].
    Horváth G; Dávid K
    Orv Hetil; 2004 Sep; 145(39):1979-84. PubMed ID: 15553908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unsaturated iron binding capacity and transferrin saturation are equally reliable in detection of HFE hemochromatosis.
    Murtagh LJ; Whiley M; Wilson S; Tran H; Bassett ML
    Am J Gastroenterol; 2002 Aug; 97(8):2093-9. PubMed ID: 12190182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
    Hicken BL; Tucker DC; Barton JC
    Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of hemochromatosis-associated mutations in Hispanic patients with iron overload.
    Nieves-Santiago P; Cancel D; Canales D; Toro DH
    P R Health Sci J; 2011 Sep; 30(3):135-8. PubMed ID: 21932715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic zinc in hemochromatosis.
    Adams PC; Bradley C; Frei JV
    Clin Invest Med; 1991 Feb; 14(1):16-20. PubMed ID: 2040101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD8+ T-lymphocyte profile as a modifier of iron overload in HFE hemochromatosis: an update of clinical and immunological data from 70 C282Y homozygous subjects.
    Cruz E; Melo G; Lacerda R; Almeida S; Porto G
    Blood Cells Mol Dis; 2006; 37(1):33-9. PubMed ID: 16762569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings.
    Adams PC; Agnew S
    Hepatology; 1996 Apr; 23(4):724-7. PubMed ID: 8666324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
    Phatak PD; Barton JC
    Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
    de Diego C; Opazo S; Murga MJ; Martínez-Castro P
    Eur J Haematol; 2007 Jan; 78(1):66-71. PubMed ID: 17042772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C.
    Sartori M; Andorno S; Pagliarulo M; Rigamonti C; Bozzola C; Pergolini P; Rolla R; Suno A; Boldorini R; Bellomo G; Albano E
    Gut; 2007 May; 56(5):693-8. PubMed ID: 17135308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis.
    Adams PC; Deugnier Y; Moirand R; Brissot P
    Hepatology; 1997 Jan; 25(1):162-6. PubMed ID: 8985284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.
    Kom GD; Schwedhelm E; Nielsen P; Böger RH
    Free Radic Biol Med; 2006 Apr; 40(7):1194-200. PubMed ID: 16545687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.